Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Organic & Biomolecular Chemistry
|
December 4, 2019
Chemical synthesis of Shiga toxin subunit B using a next-generation traceless "helping hand" solubilizing tag
James M Fulcher, Mark E Petersen, Riley J Giesler, et al.
Frontiers in Sports and Active Living
|
June 18, 2025
<i>Parkinson's Elevated</i>: improving healthspan
Kathleen E McKee, Miriam R Rafferty, Theadora W Sakata, et al.
Trials
|
March 3, 2016
Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial
Cherry-Ann Waldron, Emma Thomas-Jones, Rebecca Cannings-John, et al.
Ebiomedicine
|
August 20, 2022
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint
Navin Kumar Verma, Brandon Han Siang Wong, Zhi Sheng Poh, et al.
Journal of Virology
|
August 20, 2010
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance
Brett D Welch, J Nicholas Francis, Joseph S Redman, et al.
Blood Cancer Journal
|
August 13, 2021
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
Shin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, et al.
Hematological Oncology
|
December 27, 2024
Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore
Jing Yuan Tan, Victor Wei Teik Ling, Lawrence Cheng Kiat Ng, et al.
Leukemia & Lymphoma
|
December 28, 2024
Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study
Lawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang, et al.
Cancer Letters
|
September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma
Yichen Sun, Yan Gao, Jianfeng Chen, et al.
Molecular Cancer
|
October 16, 2021
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Organic & Biomolecular Chemistry
|
December 4, 2019
Chemical synthesis of Shiga toxin subunit B using a next-generation traceless "helping hand" solubilizing tag
James M Fulcher, Mark E Petersen, Riley J Giesler, et al.
Frontiers in Sports and Active Living
|
June 18, 2025
<i>Parkinson's Elevated</i>: improving healthspan
Kathleen E McKee, Miriam R Rafferty, Theadora W Sakata, et al.
Trials
|
March 3, 2016
Oral steroids for the resolution of otitis media with effusion (OME) in children (OSTRICH): study protocol for a randomised controlled trial
Cherry-Ann Waldron, Emma Thomas-Jones, Rebecca Cannings-John, et al.
Ebiomedicine
|
August 20, 2022
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint
Navin Kumar Verma, Brandon Han Siang Wong, Zhi Sheng Poh, et al.
Journal of Virology
|
August 20, 2010
Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance
Brett D Welch, J Nicholas Francis, Joseph S Redman, et al.
Blood Cancer Journal
|
August 13, 2021
High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma
Shin Yeu Ong, Sanjay de Mel, Nicholas Francis Grigoropoulos, et al.
Hematological Oncology
|
December 27, 2024
Impact of C-MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma-A Nationwide Retrospective Analysis in Singapore
Jing Yuan Tan, Victor Wei Teik Ling, Lawrence Cheng Kiat Ng, et al.
Leukemia & Lymphoma
|
December 28, 2024
Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective study
Lawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang, et al.
Cancer Letters
|
September 5, 2021
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma
Yichen Sun, Yan Gao, Jianfeng Chen, et al.
Molecular Cancer
|
October 16, 2021
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes
Atish Kizhakeyil, Nurmahirah Binte Mohammed Zaini, Zhi Sheng Poh, et al.
Page
of 6